BlackRock Amends Amphastar Pharma Stake (SC 13G/A)
Ticker: AMPH · Form: SC 13G/A · Filed: 2024-01-23T00:00:00.000Z
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investment
TL;DR
**BlackRock updated its passive stake in Amphastar Pharma, signaling a minor portfolio adjustment.**
AI Summary
BlackRock, Inc. filed an amended SC 13G/A on January 23, 2024, indicating a change in its ownership stake in Amphastar Pharmaceuticals, Inc. as of December 31, 2023. This filing, Amendment No. 8, shows BlackRock's updated passive investment position in the pharmaceutical company. This matters to investors because BlackRock is a major institutional investor, and changes in its holdings can signal shifts in its confidence or strategy regarding Amphastar Pharmaceuticals, potentially influencing other investors.
Why It Matters
This filing updates BlackRock's passive ownership in Amphastar Pharmaceuticals, providing transparency on a major institutional investor's position. It can influence market perception and investor sentiment towards Amphastar.
Risk Assessment
Risk Level: low — This is a routine update from a passive institutional investor and does not indicate any immediate significant risk to the company or its stock.
Analyst Insight
Smart investors would note BlackRock's continued passive interest in Amphastar Pharmaceuticals, but recognize this routine update doesn't signal a major strategic shift. They might monitor future filings for more significant changes in ownership percentage or activist intent.
Key Players & Entities
- BlackRock, Inc. (company) — the reporting person and institutional investor
- Amphastar Pharmaceuticals, Inc. (company) — the subject company whose securities are being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 23, 2024 (date) — the filing date of the SC 13G/A
- Amendment No. 8 (number) — the specific amendment number of this filing
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, as stated in the 'FORM TYPE: SC 13G/A' and 'SCHEDULE 13G (Amendment No: 8)' sections.
Who is the reporting person in this filing?
The reporting person is BlackRock, Inc., as indicated under the 'FILED BY' section and 'Names of reporting persons. BlackRock, Inc.' on the cover page.
Which company's securities are being reported on?
The securities of Amphastar Pharmaceuticals, Inc. are being reported on, as stated under 'SUBJECT COMPANY: COMPANY CONFORMED NAME: Amphastar Pharmaceuticals, Inc.' and 'AMPHASTAR PHARMACEUTICALS INC (Name of Issuer)'.
What was the date of the event that required this filing?
The date of the event which required the filing of this statement was December 31, 2023, as specified on the cover page.
Under which rule is this Schedule 13G filed?
This Schedule 13G is filed under Rule 13d-1(b), as indicated by the 'X' next to '[X] Rule 13d-1(b)' on the cover page.
From the Filing
EDGAR Filing Documents for 0001086364-24-001477 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home Company Search Current Page Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] SEC Accession No. 0001086364-24-001477 Filing Date 2024-01-23 Accepted 2024-01-23 11:53:07 Documents 1 Document Format Files Seq Description Document Type Size 1 us03209r1032_012324.txt SC 13G/A 11657 Complete submission text file 0001086364-24-001477.txt 13430 Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484 Amphastar Pharmaceuticals, Inc. (Subject) CIK : 0001297184 (see all company filings) EIN. : 330702205 | Fiscal Year End: 1231 Type: SC 13G/A | Act: 34 | File No.: 005-88204 | Film No.: 24551410 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences) Mailing Address 50 HUDSON YARDS NEW YORK NY 10001 Business Address 50 HUDSON YARDS NEW YORK NY 10001 212-810-5300 BlackRock Inc. (Filed by) CIK : 0001364742 (see all company filings) EIN. : 320174431 | State of Incorp.: DE | Fiscal Year End: 1231 Type: SC 13G/A SIC : 6211 Security Brokers, Dealers & Flotation Companies (CF Office: 02 Finance)